RNU6-62P

Across TCGA pan-cancer cohorts, RNU6-62P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RNU6-62P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-62P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-62P expression acts as an unfavorable survival marker, although some lineages such as KIRC and READ show a favorable association.

KIRC, UVM, and MESO are the cancer types where RNU6-62P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.707	0.558	<.001	142	view →
UVM	DFS	Tertile	All	0.338	0.775	<.001	135	view →
MESO	OS	Tertile	IV	0.134	0.629	.002	54	view →
READ	DFS	Quartile	III,IV	1.000	0.286	.001	37	view →
GBM	DFS	Tertile	All	0.474	0.222	.012	30	view →
HNSC	OS	Tertile	III,IV	0.445	0.718	.013	27	view →
STAD	OS	Quartile	III,IV	0.180	0.572	.001	18	view →
THCA	DFS	Tertile	IV	0.268	0.810	.001	18	view →
UCS	OS	Tertile	IV	1.000	0.293	.035	18	view →
LUAD	DFS	Tertile	III,IV	0.268	0.556	.024	14	view →
KIRP	DFS	Median	All	0.753	0.451	.003	12	view →
PRAD	DFS	Quartile	All	0.949	0.822	.001	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RNU6-62P–KIRC (OS)

Open the KIRC breakdown →